ARCHIVES

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

This article is from The Cancer Letter archive.

Vol. 28 No. 23 | June 7, 2002

Download PDF Visit The Full Archive

Related Articles

HHS Carcinogen Guidelines For Labs Could Apply To Other

May 30, 1980

Caterpillar In. Benefits Plan To Cover Entry On BMT trials

June 14, 1996

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

September 9, 1994

In Brief: Changes In Key Subcommittee chairmanships, Brooke’s Defeat Leave Direction In Doubt

November 17, 1978

Doxepin Rinse Reduces Pain In Radiation Therapy Patients

November 30, 2012

DO RFAs cut Into R01 Grant Pool? Board Asks

July 2, 1999